RIA Advisory Group LLC Purchases Shares of 5,560 Celsius Holdings, Inc. (NASDAQ:CELH)

RIA Advisory Group LLC purchased a new stake in Celsius Holdings, Inc. (NASDAQ:CELH) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 5,560 shares of the company’s stock, valued at approximately $303,000.

Several other institutional investors also recently modified their holdings of CELH. Envestnet Asset Management Inc. increased its holdings in shares of Celsius by 20.9% in the first quarter. Envestnet Asset Management Inc. now owns 5,908 shares of the company’s stock valued at $326,000 after buying an additional 1,023 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Celsius by 8.5% in the first quarter. JPMorgan Chase & Co. now owns 54,953 shares of the company’s stock valued at $3,033,000 after buying an additional 4,285 shares in the last quarter. Raymond James Financial Services Advisors Inc. raised its stake in Celsius by 4.3% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 9,583 shares of the company’s stock valued at $529,000 after purchasing an additional 398 shares during the period. Bank of New York Mellon Corp raised its stake in Celsius by 1.9% during the 1st quarter. Bank of New York Mellon Corp now owns 394,530 shares of the company’s stock valued at $21,771,000 after purchasing an additional 7,411 shares during the period. Finally, MetLife Investment Management LLC raised its stake in Celsius by 53.1% during the 1st quarter. MetLife Investment Management LLC now owns 28,662 shares of the company’s stock valued at $1,582,000 after purchasing an additional 9,946 shares during the period. Institutional investors own 60.95% of the company’s stock.

Celsius Stock Down 1.6 %

Shares of Celsius stock traded down $1.13 on Friday, hitting $68.84. 3,548,165 shares of the company traded hands, compared to its average volume of 4,759,414. The company has a 50-day moving average price of $78.59 and a 200 day moving average price of $64.07. Celsius Holdings, Inc. has a 12-month low of $29.42 and a 12-month high of $99.62. The company has a market cap of $15.90 billion, a PE ratio of 90.48, a PEG ratio of 2.07 and a beta of 1.86.

Celsius (NASDAQ:CELH) last issued its quarterly earnings data on Thursday, February 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $347.44 million during the quarter, compared to analysts’ expectations of $326.77 million. Celsius had a net margin of 17.21% and a return on equity of 131.58%. Celsius’s revenue for the quarter was up 95.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.01 earnings per share. Equities research analysts anticipate that Celsius Holdings, Inc. will post 1.09 EPS for the current year.

Insider Buying and Selling

In related news, Director Caroline S. Levy sold 20,000 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $94.77, for a total value of $1,895,400.00. Following the completion of the sale, the director now directly owns 37,891 shares in the company, valued at $3,590,930.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Celsius news, major shareholder Dean Desantis sold 100,000 shares of the company’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $95.75, for a total transaction of $9,575,000.00. Following the completion of the sale, the insider now directly owns 219,257 shares in the company, valued at $20,993,857.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Caroline S. Levy sold 20,000 shares of the company’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $94.77, for a total transaction of $1,895,400.00. Following the sale, the director now owns 37,891 shares of the company’s stock, valued at $3,590,930.07. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,034,321 shares of company stock worth $60,664,473. Corporate insiders own 2.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. UBS Group boosted their target price on shares of Celsius from $73.00 to $99.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Stifel Europe boosted their target price on shares of Celsius from $90.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, March 18th. Roth Mkm boosted their target price on shares of Celsius from $90.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, March 14th. Morgan Stanley reissued an “equal weight” rating and set a $75.00 target price on shares of Celsius in a research note on Wednesday, March 27th. Finally, Stifel Nicolaus boosted their target price on shares of Celsius from $67.00 to $90.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, Celsius presently has a consensus rating of “Moderate Buy” and a consensus price target of $85.10.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.